Debate contribution: Insulin Pumps
Debate contribution by Mr Robin Swann on .
- MLA
- Mr Robin Swann
- Party at the time
- Ulster Unionist Party
- Date
- 4 March 2024
- Type
- Debate contribution (made as a minister)
- Business
- Oral Answers to Questions
- Heading
- Insulin Pumps
- Assembly identifier
- Official Report component 4254451
Read the official Assembly record
Text
I thank the Member for her point, which is in connection with the previous supplementary. Those continuous glucose-monitoring (CGM) devices are steadily becoming a more in-demand way of monitoring diabetes control for people on intensive insulin therapy. There are many such devices available to support people living with diabetes. The NICE resource impact report on continuous glucose monitoring devices, published in March 2022, states:
"there is no advantage to recommending a specific device over another".
Therefore, the most appropriate system for each individual is the responsibility of the health and social care trusts and their clinicians to determine, in consultation with the person living with diabetes and their carer. The strategic planning group in my Department commissioned stand-alone CGM devices, and this is in line with identified commissioning needs within limited resources and as recommended in the NICE clinical guidelines for people living with diabetes. There are CGM devices currently listed on the Northern Ireland drugs tariff. Other more complex CGM devices are not currently listed on that tariff and cannot be prescribed by primary care. I will follow up with the Member. If she has written to me, I will ensure that she gets a response.
197 words. Text as published by the Northern Ireland Assembly.
Assessment
Awaiting analysis
This record has not been analysed yet. It is not counted in any total until it has been assessed.
Disagree with this assessment?
Classifications can be challenged. A person reviews every challenge, and any change is recorded publicly above with its reason.